Edesa Biotech (EDSA) Financials

$4.73

$-0.03 (-0.63%)

As on 04-Sep-2026 16:00EDT

Market cap

$46 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

114.3

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Cash From Operating Activities	--	-7.32	-4.89	-6.64	-12.28	-13.66
Cash Flow from Investing Activities	--	--	--	--	-0.01	-0.01
Cash from Financing Activities	--	17.03	0.59	4.83	11.63	14.17
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Adjusted EPS ($)	-1.69	-1.02	-1.93	-2.77	-7.67	-7.04
Cash EPS ($)	-1.72	-1.00	-1.87	-2.71	-7.62	-6.98
Adjusted Book Value ($)	0.04	1.77	0.62	2.33	4.10	6.89
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.04	-1.53	-2.19	-5.37	-7.21
Free Cash Flow per Share ($)	--	-1.04	-1.53	-2.19	-5.37	-7.21

Profitability Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
ROCE (%)	--	-99.43	-134.95	-101.18	-155.52	-133.75
ROE (%)	-123.89	-99.57	-136.66	-101.88	-156.34	-135.54
ROA (%)	-87.84	-82.86	-97.13	-81.84	-134.16	-105.28
EBIT Margin (%)	-28,293.86	--	--	--	--	-2,668,469.60
Net Margin (%)	-27,695.45	--	--	--	--	-2,668,630.00
Cash Profit Margin (%)	-0.27	--	--	--	--	--

Growth Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Revenue Growth (%)	--	--	--	--	-1.00	-1.00
EBIT Growth (%)	-145.57	-13.75	31.51	47.57	-31.84	-108.45
Net Profit Growth (%)	-138.24	-16.46	26.32	52.28	-31.52	-109.66
EPS Growth (%)	-26.91	0.47	0.30	0.64	-0.09	-0.47
Book Value Growth (%)	-51.39	--	--	--	--	--

Valuation Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Price / Earnings	--	-2.43	-2.31	-0.23	-0.12	-1.05
Price / Book Value	114.30	1.40	7.18	0.27	0.22	1.07
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.25	-0.94	-2.15	0.36	0.28	-0.47
Close Price ($)	8.13	2.47	4.45	4.41	6.44	51.66
High Price ($)	20.32	5.00	8.33	19.67	62.65	84.00
Low Price ($)	0.72	1.55	2.46	3.57	6.30	28.35
Market Cap ($ Cr)	45.60	--	--	--	--	--

Solvency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debt to Equity	--	--	0.01	0.01	0.00	0.01
Short term debt to equity ratio	--	--	0.01	0.01	0.00	0.01
Current Ratio	2.76	10.67	0.91	3.53	4.25	8.29
Quick Ratio	2.76	--	--	--	4.83	--
Interest Coverage	--	--	--	--	-21.38	-114.10

Operating Efficiency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debtors to sales (%)	447.88	--	--	--	--	660,565.40
Asset Turnover	0.00	--	--	--	--	0.00
Receivable days	--	--	--	--	--	1,238,297.21
Inventory Days	--	--	--	-2,499.32	-3,879.86	-268.88
Payable days	--	4,427.32	3,494.59	3,851.11	5,410.77	4,366.18
Cash Conversion Cycle	--	--	--	--	--	1,233,662.16

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.